Aim: Present study was done with an aim to analyse the clinicopathological and survival characteristics of male breast cancer patients. Methods: We did a retrospective review of our database and analysed total 27 patients who presented to breast oncology unit of Rajiv Gandhi cancer centre and research institute from January 2010 to April 2016. Results: Most common stage at presentation in our study was in stage II. The median follow up was 32.75 months. The actuarial 5-year survival was 92.30% and DFS was 76.30%. Only hormone receptor status was found as a significant prognostic variable among the prognostic factors studied for disease free survival. Conclusions: Carcinoma breast in male is a relatively rare disease and management principle...
Background: This retrospective study analysed the epidemiological, clinical, and therapeutic profile...
Objective: Male breast cancer (MBC) is a rare type of cancer in the breast cancer series and in the ...
BACKGROUND: Due to its rarity, male breast cancer (mBC) remains an inadequately characterized diseas...
Background Breast cancer is less common in males than females and accounts for about 1% of all malig...
Aim: Male breast cancer is a rare disease representing 1% of all breast cancers and less than 1% of...
BACKGROUND: Male breast cancer is a rare disease, accounting for 0, 1% of all cancers in men and for...
ABSTRACT Introduction Male breast cancer is an uncommon entity. Due to the scarce numbers, treatme...
BACKGROUND: Male breast cancer is a rare disease, accounting for 0, 1% of all cancers in men and for...
Objective Male breast cancer (MBC) is a rare disease representing less than 1 % of all malignancies....
Objective: Male breast cancer (MBC) is a rare type of cancer in the breast cancer series and in the ...
Aim: Male breast carcinomas are very rare tumors. In this study, we aimed to evaluate the male pati...
Objective: Male breast cancer (MBC) is a rare disease representing less than 1% of all malignancies....
BACKGROUND AND OBJECTIVESOptimal management if male breast cancer (MBC) is not clearly established a...
Male breast cancer is an uncommon disease and its aetiology, clinical behaviour and treatment is no...
Background: Carcinoma of the breast in males is of interest because it is relatively uncommon and be...
Background: This retrospective study analysed the epidemiological, clinical, and therapeutic profile...
Objective: Male breast cancer (MBC) is a rare type of cancer in the breast cancer series and in the ...
BACKGROUND: Due to its rarity, male breast cancer (mBC) remains an inadequately characterized diseas...
Background Breast cancer is less common in males than females and accounts for about 1% of all malig...
Aim: Male breast cancer is a rare disease representing 1% of all breast cancers and less than 1% of...
BACKGROUND: Male breast cancer is a rare disease, accounting for 0, 1% of all cancers in men and for...
ABSTRACT Introduction Male breast cancer is an uncommon entity. Due to the scarce numbers, treatme...
BACKGROUND: Male breast cancer is a rare disease, accounting for 0, 1% of all cancers in men and for...
Objective Male breast cancer (MBC) is a rare disease representing less than 1 % of all malignancies....
Objective: Male breast cancer (MBC) is a rare type of cancer in the breast cancer series and in the ...
Aim: Male breast carcinomas are very rare tumors. In this study, we aimed to evaluate the male pati...
Objective: Male breast cancer (MBC) is a rare disease representing less than 1% of all malignancies....
BACKGROUND AND OBJECTIVESOptimal management if male breast cancer (MBC) is not clearly established a...
Male breast cancer is an uncommon disease and its aetiology, clinical behaviour and treatment is no...
Background: Carcinoma of the breast in males is of interest because it is relatively uncommon and be...
Background: This retrospective study analysed the epidemiological, clinical, and therapeutic profile...
Objective: Male breast cancer (MBC) is a rare type of cancer in the breast cancer series and in the ...
BACKGROUND: Due to its rarity, male breast cancer (mBC) remains an inadequately characterized diseas...